221 related articles for article (PubMed ID: 15625711)
1. Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
Graves E; Hitt A; Pariza MW; Cook ME; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):48-55. PubMed ID: 15625711
[TBL] [Abstract][Full Text] [Related]
2. Indomethacin and ibuprofen preserve gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma.
McCarthy DO; Whitney P; Hitt A; Al-Majid S
Res Nurs Health; 2004 Jun; 27(3):174-84. PubMed ID: 15141370
[TBL] [Abstract][Full Text] [Related]
3. Indomethacin preserves muscle mass and reduces levels of E3 ligases and TNF receptor type 1 in the gastrocnemius muscle of tumor-bearing mice.
Hitt A; Graves E; McCarthy DO
Res Nurs Health; 2005 Feb; 28(1):56-66. PubMed ID: 15625704
[TBL] [Abstract][Full Text] [Related]
4. Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice.
Tanaka K; Urata N; Mikami M; Ogasawara M; Matsunaga T; Terashima N; Suzuki H
Inflamm Res; 2007 Jan; 56(1):17-23. PubMed ID: 17334666
[TBL] [Abstract][Full Text] [Related]
5. Characterization of a cancer cachectic factor.
Todorov P; Cariuk P; McDevitt T; Coles B; Fearon K; Tisdale M
Nature; 1996 Feb; 379(6567):739-42. PubMed ID: 8602222
[TBL] [Abstract][Full Text] [Related]
6. Central infusion of the melanocortin receptor antagonist agouti-related peptide (AgRP(83-132)) prevents cachexia-related symptoms induced by radiation and colon-26 tumors in mice.
Joppa MA; Gogas KR; Foster AC; Markison S
Peptides; 2007 Mar; 28(3):636-42. PubMed ID: 17204351
[TBL] [Abstract][Full Text] [Related]
7. Molecular analysis of the cytokine network involved in cachexia in colon 26 adenocarcinoma-bearing mice.
Yasumoto K; Mukaida N; Harada A; Kuno K; Akiyama M; Nakashima E; Fujioka N; Mai M; Kasahara T; Fujimoto-Ouchi K
Cancer Res; 1995 Feb; 55(4):921-7. PubMed ID: 7850809
[TBL] [Abstract][Full Text] [Related]
8. Ponalrestat, an aldose reductase inhibitor, inhibits cachexia syndrome induced by colon26 adenocarcinoma in mice.
Kawamura I; Lacey E; Yamamoto N; Sakai F; Takeshita S; Inami M; Nishigaki F; Naoe Y; Tsujimoto S; Manda T; Shimomura K; Goto T
Anticancer Res; 1999; 19(5B):4105-11. PubMed ID: 10628361
[TBL] [Abstract][Full Text] [Related]
9. Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo.
Strassmann G; Fong M; Freter CE; Windsor S; D'Alessandro F; Nordan RP
J Clin Invest; 1993 Nov; 92(5):2152-9. PubMed ID: 8227330
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism and treatment of cancer cachexia in tumor-bearing mice].
Li T; Li C
Zhonghua Zhong Liu Za Zhi; 1997 May; 19(3):188-91. PubMed ID: 10920893
[TBL] [Abstract][Full Text] [Related]
11. [Cytokines in experimental cancer cachexia].
Niu Q; Li T; Liu A
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):382-4. PubMed ID: 11810767
[TBL] [Abstract][Full Text] [Related]
12. Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with Lewis lung carcinoma cells.
Argilés JM; Figueras M; Ametller E; Fuster G; Olivan M; de Oliveira CC; López-Soriano FJ; Isfort RJ; Busquets S
Muscle Nerve; 2008 Feb; 37(2):190-5. PubMed ID: 17912749
[TBL] [Abstract][Full Text] [Related]
13. Combined treatment with GH, insulin, and indomethacin alleviates cancer cachexia in a mouse model.
Chen SZ; Qiu ZG
J Endocrinol; 2011 Feb; 208(2):131-6. PubMed ID: 21106721
[TBL] [Abstract][Full Text] [Related]
14. c9t11-Conjugated linoleic acid-rich oil fails to attenuate wasting in colon-26 tumor-induced late-stage cancer cachexia in male CD2F1 mice.
Tian M; Kliewer KL; Asp ML; Stout MB; Belury MA
Mol Nutr Food Res; 2011 Feb; 55(2):268-77. PubMed ID: 20827675
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice.
Siddiqui RA; Hassan S; Harvey KA; Rasool T; Das T; Mukerji P; DeMichele S
Br J Nutr; 2009 Oct; 102(7):967-75. PubMed ID: 19393114
[TBL] [Abstract][Full Text] [Related]
16. Comparison of animal models for head and neck cancer cachexia.
Cannon T; Couch M; Yin X; Guttridge D; Lai V; Shores C
Laryngoscope; 2007 Dec; 117(12):2152-8. PubMed ID: 17921906
[TBL] [Abstract][Full Text] [Related]
17. Acute inhibition of myostatin-family proteins preserves skeletal muscle in mouse models of cancer cachexia.
Benny Klimek ME; Aydogdu T; Link MJ; Pons M; Koniaris LG; Zimmers TA
Biochem Biophys Res Commun; 2010 Jan; 391(3):1548-54. PubMed ID: 20036643
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cancer cachexia in mice by combination of dsRNA-dependent protein kinase inhibitor and medroxyprogesterone acetate.
Chen SZ; Zhang YL
Oncol Rep; 2012 Feb; 27(2):579-84. PubMed ID: 22076029
[TBL] [Abstract][Full Text] [Related]
19. Conjugated linoleic acid (CLA) prevents body fat accumulation and weight gain in an animal model.
Park Y; Albright KJ; Storkson JM; Liu W; Pariza MW
J Food Sci; 2007 Oct; 72(8):S612-7. PubMed ID: 17995628
[TBL] [Abstract][Full Text] [Related]
20. Mass-dependent decline of skeletal muscle function in cancer cachexia.
Gorselink M; Vaessen SF; van der Flier LG; Leenders I; Kegler D; Caldenhoven E; van der Beek E; van Helvoort A
Muscle Nerve; 2006 May; 33(5):691-3. PubMed ID: 16372346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
